American Renal Associates (ARA) Tops Q2 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
American Renal Associates Holdings, Inc. Announces Second Quarter 2018 Results
August 7, 2018 4:05 PM EDTBEVERLY, Mass.--(BUSINESS WIRE)-- American Renal Associates Holdings, Inc. (NYSE: ARA) (the Company), a leading provider of outpatient dialysis services, today announced financial and operating results for the second quarter ended June 30, 2018.
Certain metrics, including those expressed on an adjusted basis, are Non-GAAP financial measures (See Use of Non-GAAP Financial Measures and the reconciliation tables further below).
Second Quarter 2018 Highlights (all percentage changes compare Q2 2018 to Q2 2017 unless noted):
Net patient service operating revenues increased 16.8% to $217.2 million; Net loss attributable to American Renal Associates... More